205 related articles for article (PubMed ID: 12694837)
1. IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease.
Teh BS; Bastasch MD; Wheeler TM; Mai WY; Frolov A; Uhl BM; Lu HH; Carpenter LS; Chiu JK; McGary J; Woo SY; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):184-91. PubMed ID: 12694837
[TBL] [Abstract][Full Text] [Related]
2. Predictors of extracapsular extension and its radial distance in prostate cancer: implications for prostate IMRT, brachytherapy, and surgery.
Teh BS; Bastasch MD; Mai WY; Butler EB; Wheeler TM
Cancer J; 2003; 9(6):454-60. PubMed ID: 14740973
[TBL] [Abstract][Full Text] [Related]
3. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.
Martinez AA; Yan D; Lockman D; Brabbins D; Kota K; Sharpe M; Jaffray DA; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1226-34. PubMed ID: 11483333
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma.
Chau RM; Teo PM; Choi PH; Cheung KY; Lee WY
Radiother Oncol; 2001 Feb; 58(2):143-53. PubMed ID: 11166865
[TBL] [Abstract][Full Text] [Related]
5. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
[TBL] [Abstract][Full Text] [Related]
6. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy.
De Meerleer G; Villeirs G; Bral S; Paelinck L; De Gersem W; Dekuyper P; De Neve W
Radiother Oncol; 2005 Jun; 75(3):325-33. PubMed ID: 15967524
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
[TBL] [Abstract][Full Text] [Related]
8. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer.
Yan D; Lockman D; Brabbins D; Tyburski L; Martinez A
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):289-302. PubMed ID: 10925000
[TBL] [Abstract][Full Text] [Related]
9. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
10. Analysis of dose distribution in the 'Rind'--a volume outside the PTV--in 3-dimensional conformal radiation therapy of non-small cell lung cancer.
McGibney C; Holmberg O; McClean B; Armstrong J
Radiother Oncol; 2003 Jan; 66(1):87-93. PubMed ID: 12559525
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of dosimetric margins in prostate IMRT treatment plans.
Gordon JJ; Siebers JV
Med Phys; 2008 Feb; 35(2):569-75. PubMed ID: 18383678
[TBL] [Abstract][Full Text] [Related]
12. Multiple two-dimensional versus three-dimensional PTV definition in treatment planning for conformal radiotherapy.
Stroom JC; Korevaar GA; Koper PC; Visser AG; Heijmen BJ
Radiother Oncol; 1998 Jun; 47(3):297-302. PubMed ID: 9681894
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 2D and 3D algorithms for adding a margin to the gross tumor volume in the conformal radiotherapy planning of prostate cancer.
Khoo VS; Bedford JL; Webb S; Dearnaley DP
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):673-9. PubMed ID: 9806529
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.
Parker CC; Damyanovich A; Haycocks T; Haider M; Bayley A; Catton CN
Radiother Oncol; 2003 Feb; 66(2):217-24. PubMed ID: 12648794
[TBL] [Abstract][Full Text] [Related]
16. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
[TBL] [Abstract][Full Text] [Related]
17. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of margins in pelvic lymph nodes and prostate radiotherapy and the impact of bladder and rectum on prostate position.
Marnouche EA; Hadadi K; Abdelhak M; Benlemlih M; Hommadi M; Zaghba N; Andaloussi Saghir K; Elmarjany M; Sifat H; Mansouri H
Cancer Radiother; 2021 Apr; 25(2):161-168. PubMed ID: 33454191
[TBL] [Abstract][Full Text] [Related]
19. Does Motion Assessment With 4-Dimensional Computed Tomographic Imaging for Non-Small Cell Lung Cancer Radiotherapy Improve Target Volume Coverage?
Ahmed N; Venkataraman S; Johnson K; Sutherland K; Loewen SK
Clin Med Insights Oncol; 2017; 11():1179554917698461. PubMed ID: 28469512
[TBL] [Abstract][Full Text] [Related]
20. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
